Joint Statement of AmChams in Europe ahead of the EU-U.S. Summit: A critical milestone for the global agenda


EU-U.S. Summit: A critical milestone for the global agenda For the last century, the transatlantic partnership has been the backbone of the global economy.

Chambers of Commerce of the United States in Europe, request through a joint statement that the EU-US Summit be used to promote an ambitious new Transatlantic Agenda that will strengthen commercial ties, boost economic recovery and seek new areas of cooperation and joint leadership to face shared challenges at the global level.

Consumers and producers, workers and companies, citizens and their governments across the Atlantic and beyond have benefitted from the deep integrative forces that bind the United States and Europe together. By itself, the economic relationship creates 16 million jobs, generates half of total global consumption and accounts for one third of global GDP. However, the previously undisputed leadership of the U.S. and Europe in the international system has become more precarious in recent times, as the tectonic plates of the geopolitical landscape shift. Furthermore, a oncein- a-generation global pandemic, an economic recession and a climate emergency have added to the challenges facing Transatlantic leadership.

In this context, the EU-U.S. Summit taking place on 15 June in Brussels is a critical milestone. Since the Biden Administration took office, we have seen an encouraging new momentum in the transatlantic relationship. The Summit represents an opportunity for these strategic partners to map out a positive, proactive agenda that builds on these encouraging early signs. By identifying substantive areas for cooperation, the EU and the U.S. can ensure that the transatlantic relationship continues to rhyme with prosperity, stability, welfare and leadership.

As a business community, we call for the EU and the U.S. to use the Summit to instigate a three-pronged agenda, focused on reducing barriers to trade; ensuring both sides of the Atlantic come out of the pandemic with stronger, more resilient economies; and seeking new areas for convergence and leadership as we transition towards a greener, digitalised international economy.

1. Reducing barriers to trade:


  • The business community wants to see both sides build on the positive early steps taken to resolve ongoing tariff disputes, by working together to overcome the root issues at the WTO.
  • We also call on the two sides to work to remove trade barriers by progressively pursuing by-sector agreements to reduce tariffs, as well as developing deeper regulatory cooperation.


2. Ensuring economic recovery:


  • As we move beyond the COVID-19 pandemic, it is vital that both sides fully utilise the fiscal and monetary firepower at their disposal to foster a balanced economic recovery that addresses existing structural flaws within their markets. ‘Building back better’ must be about bolstering the resilience of markets, businesses and workers to deal with future economic shocks. High ambition must be the goal on both sides of the Atlantic.
  • Travel between the U.S. and the EU must be reinstated at the earliest possible opportunity. Many industries rely on movement of people across the Atlantic – the longevity of these industries and the businesses and workers therein is at risk if the lifting of travel restrictions is delayed. 


3. Converging on a greener, digital future:


  • Emerging issues such as the climate emergency and the digital transformation will be fundamental to the future path of humanity. We need transatlantic leadership on these issues to ensure that the values that both sides espouse are deeply embedded in the economic model of tomorrow.
  • The business community wants to see the EU’s proposal for a Trade and Technology Council be taken up, as a forum to advance regulatory cooperation and mutual recognition of standards, and to avoid potential future disputes between the two sides.


The U.S. and the EU stand at an important juncture in their history. The decisions made by these strategic allies now will have a lasting impact on the future. The upcoming Summit is an opportunity to lay the foundations for the strengthened international cooperation necessary to tackle the societal challenges of our time. The next steps towards ending the pandemic, fostering economic recovery and accelerating the green and digital transitions must now be taken in Brussels, on 15 June.


Jaime Malet, Chairman of the US Chamber of Commerce in Spain highlights the importance of this summit: “the European Commission, the member states and the new US Administration must lay the foundations for a strengthened cooperation for the next few years, starting from shared values ​​and common challenges. The business community wants an ambitious transatlantic approach that returns to the path of negotiating a free trade and investment agreement. "

Malet believes that the US and the EU are at a very important moment in their history. “The decisions we make now as strategic partners will have a lasting impact in the future. The Summit is an opportunity to lay the foundations that reinforce the international cooperation necessary to face the social challenges of our time. The next steps to end the pandemic, foster economic recovery and accelerate green and digital transitions must now take place in Brussels, on June 15”.


14 Jun 2021

Interview with Eliza Tarazona, CEO of The Ribera Healthcare Group


This week we've had the pleasure to talk to one of our members, Elisa Tarazona, CEO of the Ribera Healthcare Group.

In Ribera Healthcare Group they work towards enhancing the health and well-being of the population with a management model which adds value to society and contributes to the sustainability of the healthcare systems.


Tell us briefly about the history of RIBERA SALUD and its mission.

Ribera is a business group that was founded in 1997, providing public and private healthcare services. Our mission is to transform the way of working and innovate healthcare management to improve the health and well-being of the population. Our healthcare model is studied as a success story in well-known international universities such as Harvard Business School and Berkeley. We have more than 6,500 professionals in the different projects in which we participate. We are present in four autonomous regions of Spain with eight hospitals, three of which are university hospitals, and more than 60 health centers in the Valencian Community and the Communities of Madrid, Galicia and Extremadura. In Europe we have a radiology and nuclear medicine company, a leader in Slovakia, and a clinic specialized in highly complex surgery in the Czech Republic. We were involved in launching the first two hospitals in Latin America with the PPP model, which are in Peru, and we also have a purchasing center, Ribera B2b, a laboratory division, Ribera Lab, and a technological affiliate, futuRS. Ribera's shareholders are the American insurance company Centene Corporation (90%) and Banco Sabadell (10%).

Tell us about your professional career and your role in RIBERA SALUD.

I have a degree in Medicine and Surgery and a PhD in Medicine from the University of Valencia and I'm a specialist in Family and Community Medicine. In addition, I trained in healthcare management at the Polytechnic University of Valencia, ESADE and IESE. I started as an attending physician at the Hospital-at-Home Unit at La Fe University Hospital and later became the Head of Primary Care in the healthcare area of La Fe. In 2003 I joined the Ribera healthcare group as Deputy Manager of La Ribera's Health Department (Alzira) and, in 2008, I took on Care Management and Organizational Management of the group and, later, Operations management and Project Integration. Since October 2020 I have been the Chief Executive Officer (CEO) of the Ribera group, during an especially intense period filled with challenges, with the progressive growth of the company and the expansion and diversification of healthcare services, such as the new laboratory and radiodiagnostic units, and private medical services, with a basic objective: to continue to provide citizens with integrated care, in order to take better care of their health and well-being.

Which aspect is it that makes RIBERA SALUD stand out or of which do you feel most proud?

At Ribera Group we are, and we feel, responsible for the health of the citizens. Therefore, the population to which we attend is always our priority. We have demonstrated this once again with the management of this pandemic in our hospitals and Primary Care centers, being committed to clinical management, anticipating decision making and ensuring coordination between our centres and with local authorities. With the citizens at the heart of every decision that we make, we are committed to innovation and technology, in order to give them access to results from diagnostic tests and tele-consultations. However, we also work on launching applications that now allow us to telemonitor patients, for example those with cardiac insufficiency, or anticipate clinical decisions regarding Covid patients, thanks to a model that predicts which of these patients will end up in the ICU.

Why did you choose to become a partner of AmChamSpain?

The majority shareholder of the Ribera healthcare group is Centene Corporation (90%), one of the leading companies in the American healthcare insurance sector, included in the Fortune 50 list. Centene has more than 30 years experience collaborating with state governments in the United States and is one of the main providers for the Medicare and Medicaid programs. The United States Chamber of Commerce in Spain is another bridge which connects Ribera to our main shareholder's country and to all those companies and institutions that, like the Ribera group and Centene, want to transform and innovate with their projects and generate opportunities and employment on both sides of the ocean.

Any advice, good practice or special input from RIBERA SALUD in the face of the current global situation.

In Ribera we like to say that we work today for the healthcare of tomorrow, and that we contribute to the long-term sustainability of healthcare services with our model. We are committed to medicine based on the 5ps: personalized, population-based, participatory, predictive and preventative. Healthcare expenditure is continuing to grow at an unstoppable rate, and the pandemic has increased waiting lists, which has a great impact on health services; in addition to the consequences of the pandemic which have yet to come. In this situation, we believe it is necessary to have all of the resources, include companies and be committed to public-private collaboration, in order to manage health in a responsible way, something for which the Ribera group advocates.

11 May 2021